Answers are grounded in this paper and cite their sources.
Structure-based design of SARS-CoV-2 main protease inhibitors identified hydantoin, benzothiazine and cresol moieties as promising residues of new peptidomimetic inhibitors.
No takes yet. Share an insight, caveat, or question.
Frecer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: